Study of: Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung Cancer (NSCLC) Based on Specific Genetic Alterations
Author(s) Details: Abdullah M. Nasrat Zaitona Medical Center, Medina, Saudi Arabia. Rania Ashour Al Hayat National Hospital, Medina, Saudi Arabia. This section is a part of the chapter: Tirosine Kinase Inhibitors (TKI) Used in the Treatment of Non-Small Cell Lung…